Part of an interim Enbrel manufacturing site at West Greenwich owned by Wyeth-Ayerst Pharmaceuticals and using Immunex's process technology.
-
Immunex decided to purchase an existing manufacturing facility in West... -
Work on the BioNext project in West Greenwich began in November 2001. -
Immunex has also recently invested in a pharmaceutical facility in Bothell in... -
Part of an interim Enbrel manufacturing site at West Greenwich owned by... -
The plant is now fully operational. -
The water treatment plant will use 800,000 gallons per day.
Twitter